PUBLISHER: The Business Research Company | PRODUCT CODE: 1957406
PUBLISHER: The Business Research Company | PRODUCT CODE: 1957406
Medical device clinical trials are research studies designed to evaluate the safety and effectiveness of medical devices in humans. The process includes phases such as feasibility, pivotal, and post-approval studies, which are necessary for regulatory approval. These trials generate critical data to support device market authorization and ongoing safety monitoring.
The main study types in medical device clinical trials include feasibility and pilot studies, pivotal studies, FDA premarket approval (PMA) applications, and post-approval studies. Feasibility and pilot studies are early-phase trials conducted with a small group of participants to assess the practicality, safety, and potential challenges of a new device before progressing to larger trials. These studies are conducted across various indications, including cardiovascular, neurology, orthopedic, diagnostic imaging, anesthesia and respiratory devices, and others. Study designs typically include interventional, observational, and expanded access approaches.
Tariffs have influenced the medical device clinical trials market by increasing costs for imported trial devices, monitoring equipment, and data collection technologies. These impacts are most evident in cardiovascular, orthopedic, and diagnostic device trials, particularly across North America, Europe, and Asia-Pacific regions. Higher tariffs have raised overall trial execution costs and delayed multinational study timelines. However, tariffs have also encouraged local trial execution, regional manufacturing of investigational devices, and increased domestic clinical research capacity.
The medical device clinical trials market research report is one of a series of new reports from The Business Research Company that provides medical device clinical trials market statistics, including medical device clinical trials industry global market size, regional shares, competitors with a medical device clinical trials market share, detailed medical device clinical trials market segments, market trends and opportunities, and any further data you may need to thrive in the medical device clinical trials industry. This medical device clinical trials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The medical device clinical trials market size has grown strongly in recent years. It will grow from $18.07 billion in 2025 to $19.36 billion in 2026 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to growth in medical device innovation, stringent regulatory approval requirements, rising demand for patient safety validation, expansion of hospital-based clinical research, increasing investment in clinical evidence generation.
The medical device clinical trials market size is expected to see strong growth in the next few years. It will grow to $25.35 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to growth in wearable and connected medical devices, increasing regulatory scrutiny on device performance, expansion of digital trial platforms, rising adoption of remote patient monitoring in trials, increasing globalization of clinical studies. Major trends in the forecast period include increasing adoption of decentralized clinical trials, growing use of real-world evidence in device trials, rising focus on post-approval and long-term safety studies, expansion of adaptive and hybrid trial designs, increasing demand for regulatory-compliant trial management.
The increasing prevalence of chronic diseases is expected to drive the growth of the medical device clinical trials market in the coming years. Chronic diseases are long-term health conditions that progress gradually and require ongoing medical management. Their rise is linked to sedentary lifestyles, where extended periods of sitting or screen use reduce calorie expenditure and weaken cardiovascular health, contributing to conditions such as obesity, diabetes, and hypertension. The growing burden of chronic diseases fuels the need for medical device clinical trials to develop and validate innovative devices for effective diagnosis, treatment, and disease management. For example, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people worldwide were living with diabetes, a number projected to more than double to 1.3 billion by 2050. Consequently, the rising prevalence of chronic diseases is driving the expansion of the medical device clinical trials market.
Major companies in the medical device clinical trials market are focusing on developing AI-powered medical device software to optimize clinical trial protocols, streamline resource allocation, and enhance trial efficiency while reducing costs. AI-powered medical device software uses artificial intelligence, including machine learning and deep learning algorithms, to support or automate healthcare tasks. For example, in January 2025, Risklick, a Switzerland-based pharmaceutical company, launched Protocol AI, an AI-based software designed to accelerate and optimize clinical trials for medical devices. Protocol AI employs Natural Language Processing (NLP) and Machine Learning (ML) to analyze clinical data, publications, and regulatory documents, automatically generating clinical trial protocols in minutes. This innovation significantly reduces the time and cost of protocol development, which traditionally takes around six months, and has demonstrated up to a 50% reduction in document preparation time for medicinal products.
In January 2024, eMed, a US-based health services company, acquired Science 37 for $38 million. The acquisition enhances eMed's clinical research capabilities by integrating telehealth and diagnostic services with decentralized trial technology, improving patient enrollment and expanding access to underrepresented populations. Science 37 is a US-based research company specializing in decentralized clinical trials, including those for medical devices.
Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG
North America was the largest region in the medical device clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the medical device clinical trials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The medical device clinical trials market includes revenues earned by entities by providing services such as clinical trial design and management, regulatory consulting, site selection and monitoring, patient recruitment, data management, and statistical analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The medical device clinical trials market also includes sales of diagnostic devices, therapeutic devices, surgical instruments, monitoring equipment, implantable devices, wearable health technologies, and medical imaging systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medical Device Clinical Trials Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses medical device clinical trials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for medical device clinical trials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical device clinical trials market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.